VAERS Explorer
Back to explore

Report #2853938

Received Aug 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
61 yrs
State
PA
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNA2—IM

Symptoms (1)

Guillain-Barre syndrome

Symptom narrative

GBS - loss of function in extremities 8 days post 2nd moderna covid vaccination; This spontaneous case was reported by a consumer and describes the occurrence of GUILLAIN-BARRE SYNDROME (GBS - loss of function in extremities 8 days post 2nd moderna covid vaccination) in a 61-year-old male patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. In 2023, the patient received second dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. In 2023, after starting SPIKEVAX NOS (SPIKEVAX NOS), the patient experienced GUILLAIN-BARRE SYNDROME (GBS - loss of function in extremities 8 days post 2nd moderna covid vaccination) (seriousness criterion medically significant). At the time of the report, GUILLAIN-BARRE SYNDROME (GBS - loss of function in extremities 8 days post 2nd moderna covid vaccination) had resolved with sequelae. No concomitant medications were reported. It was unknown if the patient experienced any additional symptoms or events. The patient did not know the details of medication and reason for taking the medicine. No treatment medications were reported.; Reporter's Comments: The benefit -risk relationship of product is not affected by this report.